Astellas Institute for Regenerative Medicine v.Osaka University and Healios K.K.
Munich (DE) Central Division - Section · UPC-001560
This is a revocation action concerning European Patent No. EP3056564, owned by Healios K.K and Osaka University, brought by Astellas Institute for Regenerative Medicine before the Central Division (Section Munich) of the Unified Patent Court. Following an interim conference held on 13 March 2024, the judge-rapporteur issued a procedural order addressing the admissibility of a second declaration (D21), setting the value of the dispute at EUR 4,000,000 for cost ceiling purposes, establishing deadlines for cost-related submissions, and confirming the oral hearing date for 26 June 2024.